JP2023175708A5 - - Google Patents

Download PDF

Info

Publication number
JP2023175708A5
JP2023175708A5 JP2023136194A JP2023136194A JP2023175708A5 JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5 JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5
Authority
JP
Japan
Prior art keywords
autoantigen
alpha
synuclein
kit according
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023136194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023175708A (ja
JP7628333B2 (ja
Filing date
Publication date
Priority claimed from JP2018541534A external-priority patent/JP7378931B2/ja
Application filed filed Critical
Publication of JP2023175708A publication Critical patent/JP2023175708A/ja
Publication of JP2023175708A5 publication Critical patent/JP2023175708A5/ja
Application granted granted Critical
Publication of JP7628333B2 publication Critical patent/JP7628333B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023136194A 2015-11-03 2023-08-24 ヒト患者における自己抗原に対するワクチン接種法 Active JP7628333B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15192794 2015-11-03
EP15192794.4 2015-11-03
JP2018541534A JP7378931B2 (ja) 2015-11-03 2016-11-02 ヒト患者における自己抗原に対するワクチン接種法
PCT/EP2016/076372 WO2017076873A1 (en) 2015-11-03 2016-11-02 Method for vaccination against a self-antigen in a human patient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018541534A Division JP7378931B2 (ja) 2015-11-03 2016-11-02 ヒト患者における自己抗原に対するワクチン接種法

Publications (3)

Publication Number Publication Date
JP2023175708A JP2023175708A (ja) 2023-12-12
JP2023175708A5 true JP2023175708A5 (cg-RX-API-DMAC7.html) 2024-04-01
JP7628333B2 JP7628333B2 (ja) 2025-02-10

Family

ID=54396782

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018541534A Active JP7378931B2 (ja) 2015-11-03 2016-11-02 ヒト患者における自己抗原に対するワクチン接種法
JP2023136194A Active JP7628333B2 (ja) 2015-11-03 2023-08-24 ヒト患者における自己抗原に対するワクチン接種法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018541534A Active JP7378931B2 (ja) 2015-11-03 2016-11-02 ヒト患者における自己抗原に対するワクチン接種法

Country Status (10)

Country Link
US (1) US12290553B2 (cg-RX-API-DMAC7.html)
EP (1) EP3370761A1 (cg-RX-API-DMAC7.html)
JP (2) JP7378931B2 (cg-RX-API-DMAC7.html)
KR (1) KR102857456B1 (cg-RX-API-DMAC7.html)
CN (1) CN108472344A (cg-RX-API-DMAC7.html)
AU (1) AU2016348610B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018008697A2 (cg-RX-API-DMAC7.html)
CA (1) CA3003943A1 (cg-RX-API-DMAC7.html)
RU (1) RU2734924C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017076873A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003943A1 (en) * 2015-11-03 2017-05-11 Affiris Ag Method for vaccination against a self-antigen in a human patient
AR111760A1 (es) * 2017-05-19 2019-08-14 Novartis Ag Compuestos y composiciones para el tratamiento de tumores sólidos mediante administración intratumoral
JP2021525074A (ja) * 2018-05-22 2021-09-24 ザ・ガバナーズ・オブ・ザ・ユニバーシティー・オブ・アルバータ 構造に基づくアミロイド疾患ワクチン及び抗原のための無害な構造化足場
JP7898188B2 (ja) 2020-08-04 2026-07-31 エイシー イミューン ソシエテ アノニム 免疫原性化合物
KR102527616B1 (ko) 2021-03-18 2023-05-02 정성욱 항체 관련 정보를 제공하는 방법 및 디바이스
IL314865A (en) 2022-02-09 2024-10-01 Ac Immune Sa Anti-alpha-synuclein therapeutic vaccines
WO2025172592A1 (en) 2024-02-15 2025-08-21 Ac Immune Sa Alpha synuclein therapeutic vaccine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101077416A (zh) 2002-10-23 2007-11-28 葛兰素史密丝克莱恩生物有限公司 抗疟疾的疫苗接种方法
AT413945B (de) 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT506535B1 (de) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
AT508569A1 (de) 2009-07-23 2011-02-15 Affiris Ag Pharmaceutical compound
AT508638B1 (de) 2009-08-21 2011-08-15 Affiris Ag Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
KR101660578B1 (ko) 2009-09-03 2016-09-27 화이자 백신스 엘엘씨 Pcsk9 백신
JP5814933B2 (ja) 2009-12-15 2015-11-17 ノバルティス アーゲー 免疫増強化合物の均質な懸濁物およびその使用
EP2659907A1 (en) 2012-05-01 2013-11-06 Affiris AG Compositions
EP2666785A1 (en) 2012-05-23 2013-11-27 Affiris AG Complement component C5a-based vaccine
EP2703483A1 (en) 2012-08-29 2014-03-05 Affiris AG PCSK9 peptide vaccine
PL3110439T3 (pl) 2014-02-28 2019-09-30 Affiris Ag Szczepionki PCSK9
CA3003943A1 (en) * 2015-11-03 2017-05-11 Affiris Ag Method for vaccination against a self-antigen in a human patient

Similar Documents

Publication Publication Date Title
TWI232753B (en) Adjuvant compositions comprising QS-21,3D-MPL and CpG and vaccine compositions comprising the same
ES2179105T5 (es) Adyuvantes proteinicos.
JP2018532782A5 (cg-RX-API-DMAC7.html)
Brennan et al. Cowpea mosaic virus as a vaccine carrier of heterologous antigens
ES2141750T5 (es) Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno.
CN102256620B (zh) 用于治疗阿尔茨海默氏病的免疫治疗组合物
JP2009191078A5 (cg-RX-API-DMAC7.html)
De Haan et al. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice
RU2007145052A (ru) Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера
Levi et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes
JP2011042693A5 (cg-RX-API-DMAC7.html)
WO2002024224A2 (en) Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
Migliorini et al. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity
RU2018120009A (ru) Способ вакцинации против аутоантигена у пациента-человека
WO2013164354A1 (en) Composition
JP2007513992A (ja) 自己免疫疾患の治療用のil−12又はil−23を含むワクチン
AU2016271857B2 (en) IL-23-P19 vaccines
RU2130778C1 (ru) Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка, дифтерии и коклюша
MXPA06009805A (es) Peptidos de interleucina 1 beta y factor de necrosis tumoral alfa y metodo de tratamiento utilizando los mismos.
US20080311152A1 (en) Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
US8575319B2 (en) Cleavable vaccine compositions and uses thereof and methods of making and using the same
JP4889175B2 (ja) 感染性因子に対する免疫応答を刺激するための組成物および方法
WO1998046263A1 (en) Saponin adjuvants in combination with dna vaccination
Allison Antigens and adjuvants for a new generation of vaccines
RU2130779C1 (ru) Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка и дифтерии